Life Insurance After Colon Cancer: Stage, CEA Levels, and Rates

Yes — most colon and colorectal cancer survivors can qualify for life insurance, and early-stage cases are often among the more favorably underwritten cancer histories. Stage at diagnosis, time since treatment, and clean follow-up colonoscopies are what carriers focus on most — though waiting periods and rate outcomes vary significantly by carrier.

Colorectal cancer is one of the most common cancers diagnosed in the U.S., and because outcomes vary significantly by stage, underwriters have well-developed guidelines for evaluating it. Here’s what to expect.

How underwriters evaluate colon and colorectal cancer

Underwriters look at four main factors: the stage at diagnosis, whether the cancer was in the colon or rectum, the treatment received, and how much time has passed since treatment ended with no recurrence. Lymph node involvement and tumor grade also factor into the picture, especially for Stage II and III cases.

Because outcomes for colorectal cancer differ so much by stage — from highly localized polyps to more advanced disease — carriers treat this diagnosis with real nuance rather than a single blanket approach. It’s also worth knowing upfront that colon cancer tends to draw more underwriting scrutiny than some other cancer types, and waiting periods can run longer than you might expect even at earlier stages.

Rates and eligibility by stage

The waiting periods and rate outcomes below reflect general patterns reported across the industry. They are not guarantees — actual outcomes depend heavily on which carrier reviews your case, your specific pathology, and your surveillance record. Some carriers are notably more conservative on colon cancer than others.

Stage 0 (carcinoma in situ) and precancerous polyps. Often treated similarly to a precancerous condition rather than invasive cancer. Some carriers offer standard rates within one to two years of removal, though others may apply a modest rating for several years before moving to standard.

Stage I. Highly treatable with excellent long-term outcomes. Some carriers will consider standard rates as early as one to three years post-treatment, but many require three to five years — or longer — before offering their best available rates, and a rating during the interim years is common.

Stage II. Outcomes vary widely by carrier. Some may offer a rated policy within one to three years, while others require three to five years or more before considering standard rates, particularly if high-risk features were present.

Stage III. Coverage is available but the carrier pool narrows meaningfully, particularly with lymph node involvement. Waiting periods of five years or more are common before standard or near-standard rates become available, and some carriers may decline until well past that point.

Stage IV. Traditional coverage through standard carriers is generally not available. Guaranteed issue whole life insurance is the realistic path to coverage in this situation.

Because the range of outcomes is so wide, the single most useful thing you can do is have your specific case pre-screened with multiple carriers before applying, rather than assuming any general timeline applies to you.

What helps your application

Surveillance colonoscopies. Underwriters want to see documented follow-up colonoscopies showing no recurrence, typically on a one-, three-, and five-year schedule after treatment. A clean, consistent surveillance record is one of the strongest things you can bring to an application.

CEA monitoring. Carcinoembryonic antigen (CEA) is a tumor marker tracked after colorectal cancer treatment. A stable or normal CEA level across multiple tests is a positive underwriting signal, similar to how PSA is used for prostate cancer.

Lymph node status. Cases where no lymph nodes were involved at diagnosis are generally viewed more favorably than cases with node involvement, even at the same overall stage.

Family history and genetic factors. If your colorectal cancer was linked to a hereditary condition like Lynch syndrome or familial adenomatous polyposis, disclose it. Some carriers factor this into their evaluation, but it does not automatically disqualify you, especially with a strong ongoing surveillance plan.

What rates actually look like

To show what a real difference in outcome can look like, here’s an actual comparison. A healthy 52-year-old non-smoker male in Nevada with no cancer history and standard health currently qualifies for roughly $155 to $163 per month for $500,000 of 20-year term coverage across the carriers we checked as of August 2026.

A colon cancer history typically results in a rated premium above that healthy baseline — insurance carriers commonly apply what’s called a “flat extra,” an additional charge per $1,000 of coverage that runs for a set number of years, often in addition to or instead of a standard table rating. The size of that surcharge depends heavily on stage, time since treatment, and which carrier reviews the case; it can range from a modest addition to a significantly higher premium than the healthy baseline above, and some cases may not qualify for standard underwriting at all during the early years.

The spread between carriers on colorectal cancer cases can be significant — one carrier may offer a much more favorable rating than another for the exact same case. This is where an independent broker makes a measurable difference — matching your specific diagnosis and surveillance record to the carrier most likely to offer the best outcome, rather than accepting the first offer you receive.

Frequently Asked Questions

Can you get life insurance after colon or colorectal cancer?
Yes. Most survivors can qualify for life insurance, particularly with an early stage at diagnosis, clean surveillance colonoscopies, and enough time since treatment. Outcomes vary significantly by carrier, so working with a broker who can shop your specific case matters.

How long after colon cancer treatment can I apply for life insurance?
This depends heavily on stage and carrier. Some carriers will consider early-stage cases within one to three years, while others require significantly longer — five years or more is common for Stage II and III, and colon cancer generally draws more cautious underwriting than some other cancer types.

Does CEA level affect my life insurance application?
Yes. A stable or normal CEA level across multiple post-treatment tests is a positive signal to underwriters, similar to how PSA is used in prostate cancer cases.

Does lymph node involvement affect my rate?
Yes. Cases with no lymph node involvement at diagnosis are generally viewed more favorably than cases with node involvement, even within the same overall stage.

What if I have a hereditary condition linked to my colorectal cancer, like Lynch syndrome?
Disclose it. Some carriers factor hereditary conditions into their evaluation, but it does not automatically disqualify you, particularly with a strong ongoing surveillance plan in place.

What to do before you apply

Gather your treatment summary. Your oncologist or surgeon can provide a summary documenting your original diagnosis, stage, treatment received, and current surveillance status.

Stay current with surveillance colonoscopies. Consistent follow-up on the recommended schedule is one of the strongest signals of stability you can bring to an application.

Be transparent about your full history. Cancer history appears in medical records without exception. Disclosing it accurately and proactively is always the right approach — omissions can result in a denied claim later.

Work with a broker who places colorectal cancer cases regularly. Carrier guidelines vary enormously for this diagnosis, and waiting periods are not standardized across the industry. The right match can be the difference between a decline and an approval, or between a heavy rating and a mild one.

If you’re also working out how much coverage you need, our life insurance needs calculator is a good starting point.

Get your free quote today

At Term Insurance Brokers, colorectal cancer cases are part of what we handle every week. We’re licensed independent insurance agents representing more than 30 top-rated carriers and know exactly which ones take the most favorable view of your specific stage, treatment history, and surveillance record.

There’s no cost for a quote and no obligation. We do the carrier comparison — you make the decision.

---

Term Insurance Brokers is a team of licensed independent insurance agents operating in 35+ states, based in Las Vegas, Nevada. We are not affiliated with any single insurance company. Sample non-cancer-history rate shown reflects current market pricing as of August 2026 for a 52-year-old male applicant in Nevada; actual premiums for any applicant, with or without a cancer history, depend on full underwriting and carrier guidelines at time of application.